L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard Stephen Sunderland Read more
Related Practice MedTech Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption 07102020100744
Case Study Life Sciences & Pharma Developing and Operationalizing Omnichannel Capabilities in the Pharmaceutical Market November 12, 2025
Video / Webinar Life Sciences & Pharma China’s Innovation Momentum: Powered by Life Science Research Tools and Enablers October 14, 2025
Published Articles Life Sciences & Pharma From Bench to Bedside: Academic-to-Industry Translation in European Biopharma August 27, 2025
Executive Insights Healthcare Services A View Into the Promise of Continuous Manufacturing June 30, 2025
Executive Insights Life Sciences & Pharma Radiotherapeutics on the Rise: Addressing Supply Chain Complexity April 7, 2025
Case Study Life Sciences & Pharma Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company March 31, 2025 A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…
